Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IS
$ 11.73
-2.82 %
$ 3.54 B
Market Cap
-4.55
P/E
INCOME STATEMENT
91.4 M
REVENUE
-355 M
OPERATING INCOME
-552 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Alvotech
| Revenue | 91.4 M |
| Cost Of Revenue | 161 M |
| Gross Profit | -69.4 M |
| Operating Expenses | 285 M |
| Operating Income | -355 M |
| Other Expenses | 197 M |
| Net Income | -552 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 91.4 | 83.0 | 36.8 | 66.6 | 31.9 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 160.9 | 64.1 | 0 | 0 | 0 |
| Gross Profit | (69.4) | 18.9 | 36.8 | 66.6 | 31.9 |
| OPERATING INCOME | |||||
| Operating Expenses | 285.4 | 365.4 | 272.2 | 204.2 | 93.4 |
| Selling, General and Administrative Expenses | 76.6 | 186.7 | 84.1 | 58.9 | 48.6 |
| Research and Development Expenses | 210.8 | 180.6 | 191.0 | 148.1 | 95.6 |
| Operating Income | (354.9) | (346.4) | (235.5) | (137.5) | (61.4) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 134.8 | 188.4 | 117.4 | 97.5 | 95.8 |
| Total Other Income | (296.2) | (205.2) | 86.3 | (154.2) | (147.9) |
| Pre-Tax Income | (651.0) | (551.6) | (149.2) | (291.8) | (209.4) |
| NET INCOME | |||||
| Tax Provision | (99.3) | (38.1) | (47.7) | (121.7) | 0.5 |
| Net Income | (551.7) | (513.6) | (101.5) | (170.0) | (209.9) |
| EPS | 2.43 | 2.6 | 3.25 | 5.44 | 0.86 |